Wolters Kluwer Health - Lippincott Williams & Wilkins

Registered Users

User Name:
Password:
Register   Forgotten Password
Enter your email address:
  • Conferences
  • Free Content
  • Hot Topics
  • News
  • Archive
  • Contact Us
  • Home
  • Publish With Us
  • Partnerships in Focus
  • Current Focus
  • Conference Focus
  • Society Partners
  • News
  • Contact Us
  • Resources
  • Download Centre
  • About Us
  • Sustainability
  • Register

Cancer Prevention banner

You are here: Home » Oncology » DNA damage and repair in melanoma patients

DNA damage and repair in leukocytes of melanoma patients exposed in vitro to cisplatin

Cover of Melanoma ResearchShimabukuro et al
Melanoma Research 21 (2) April 2011
ISSN: 0960-8931 • Frequency: 6/year • Subscribe Now

This study aims to assess the basal DNA damage in peripheral blood leukocytes of patients with melanoma at an early stage, and assess, in vitro, the response to cisplatin in the leukocytes of the same patients and cancer-free controls using the Comet assay.

Read this Introduction / Read this Article 

 

 



Don't miss out - further Free LWW Content is available for registered users! Log into your account or register here to read these articles

 

Bookmark and Share

Oncology button
Radiology button
Pathology Archive
Mental Health button
HIV AIDS Focus
Emergency Medicine button
Gastroenterology button
Neurology button
Cardiology button
Infectious Diseases Archive
Aneasthesiology Archive
Conferences


©2012 Lippincott Williams & Wilkins
Judd Associates: Sussex Web Design
  • Site Map
  • Accessibility
  • Privacy
Follow us on Facebook and Twitter